Education
About Us
Working with TipRanks
Follow Us
Neurogene (NGNE)
NASDAQ:NGNE
Neurogene (NGNE) Ownership Overview
21.83% Insiders
12.06% Mutual Funds
<0.01% Other Institutional Investors
9.41% ETFs
56.70% Public Companies and
Individual Investors
The ownership structure of Neurogene (NGNE) stock is a mix of institutional, retail, and individual investors. Approximately 21.47% of the company’s stock is owned by Institutional Investors, 21.83% is owned by Insiders, and 56.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 17, 2025 | xxxxxxxxxxxxx | $76247 | |
Nov 27, 2024 | xxxxxxxxxxxxx | $1259623 | |
Nov 25, 2024 | xxxxxxxxxxxxx | $491280 | |
Nov 25, 2024 | xxxxxxxxxxxxx | $969000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $1253333 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $14825780 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,717,127 | Insider | 12.03% | 35,218,275 | |
| 1,274,259 | Insider | 8.93% | 26,135,052 | |
| 991,691 | Institution | 6.95% | 20,339,582 | |
| 528,436 | Institution | 3.70% | 10,838,222 | |
| 527,904 | Institution | 3.70% | 10,827,311 | |
| 446,880 | Institution | 3.13% | 9,165,509 | |
| 446,224 | Institution | 3.13% | 9,152,054 | |
| 409,141 | Institution | 2.87% | 8,391,482 | |
| 200,681 | Institution | 1.41% | 4,115,967 | |
| 133,968 | Institution | 0.94% | 2,747,684 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 528,436 | Institution | 3.70% | 10,838,222 | |
| 409,141 | Institution | 2.87% | 8,391,482 | |
| 133,968 | Institution | 0.94% | 2,747,684 | |
| 106,351 | Institution | 0.75% | 2,181,259 | |
| 69,195 | Institution | 0.48% | 1,419,189 | |
| 57,914 | Institution | 0.41% | 1,187,816 | |
| 33,969 | Institution | 0.24% | 696,704 | |
| 31,880 | Institution | 0.22% | 653,859 | |
| 22,667 | Institution | 0.16% | 464,900 | |
| 7,268 | Institution | 0.05% | 149,067 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 364,893 | Institution | 2.56% | 7,943,721 | |
| 244,935 | Institution | 1.72% | 5,023,617 | |
| 108,939 | Institution | 0.76% | 2,371,602 | |
| 85,128 | Institution | 0.60% | 1,719,586 | |
| 72,317 | Institution | 0.51% | 1,483,222 | |
| 56,082 | Institution | 0.39% | 1,132,856 | |
| 56,082 | Institution | 0.39% | 1,132,856 | |
| 56,082 | Institution | 0.39% | 1,132,856 | |
| 46,989 | Institution | 0.33% | 1,022,951 | |
| 44,904 | Institution | 0.31% | 907,061 |
FAQ
Who Owns Neurogene (NGNE)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 21.83% is held by insiders, and 56.70% is held by retail investors.
What percentage of Neurogene (NGNE) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Neurogene (NGNE) stock is held by institutional investors.
What percentage of Neurogene (NGNE) stock is held by retail investors?
According to the latest TipRanks data, approximately 56.70% of Neurogene (NGNE) stock is held by retail investors.
Who owns the most shares of Neurogene (NGNE)?
Samsara BioCapital GP, LLC owns the most shares of Neurogene (NGNE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.